THYROID GLAND ANAPLASTIC CARCINOMA
Clinical trials for THYROID GLAND ANAPLASTIC CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new THYROID GLAND ANAPLASTIC CARCINOMA trials appear
Sign up with your email to follow new studies for THYROID GLAND ANAPLASTIC CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for fighting rare, Fast-Growing thyroid cancer
Disease control OngoingThis study is testing whether combining a drug that helps the immune system fight cancer (atezolizumab) with different chemotherapy drugs can help people with aggressive forms of thyroid cancer that have spread or cannot be removed by surgery. The goal is to see if this combinati…
Matched conditions: THYROID GLAND ANAPLASTIC CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Three-Pronged attack tested to tame deadly thyroid cancer before surgery
Disease control OngoingThis study is testing a combination of three drugs given before surgery for patients with a very aggressive type of thyroid cancer that has a specific genetic change (BRAF V600E mutation). The goal is to shrink the tumor and make it easier to remove completely during surgery, whi…
Matched conditions: THYROID GLAND ANAPLASTIC CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Scientists train Patients' own cells to fight advanced cancers
Disease control OngoingThis study is testing a personalized cell therapy called LN-145 for patients with advanced cancers that have stopped responding to standard treatments. Doctors collect a patient's own immune cells from their tumor, grow large numbers of them in a lab, and then infuse them back in…
Matched conditions: THYROID GLAND ANAPLASTIC CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New drug aims to shrink tough thyroid tumors before surgeons operate
Disease control OngoingThis study is testing whether a targeted pill called selpercatinib can shrink thyroid tumors before surgery. It is for people with advanced thyroid cancer that has a specific genetic change (RET alteration). The goal is to see if shrinking the tumor first makes surgery easier and…
Matched conditions: THYROID GLAND ANAPLASTIC CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC